CD99-positive "Ewing's sarcoma" from mouse bone marrow-derived mesenchymal progenitor cells? [1]

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9786-

  Kovar, Heinrich ^a   Bernard, Alain ^b  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; RNA BINDING PROTEIN EWS;

BONE MARROW; EWING SARCOMA; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; LETTER; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID MOTIFS; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, NEOPLASM; BONE MARROW CELLS; BONE NEOPLASMS; CELL LINEAGE; EPITOPES; IMMUNOCHEMISTRY; MESENCHYMAL STEM CELLS; MICE; ONCOGENE PROTEINS, FUSION; PANCREAS; SARCOMA, EWING'S; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 33750310480     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0205     Document Type: Letter

References (5)

1. Riggi N, Cironi L, Provero P, et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 2005;65:11459-68.
2. Dracopoli NC, Rettig WJ, Albino AO, et al. Genes controlling gp25/30 cell surface molecules map to chromosome X and Y, escape X-inactivation. Am J Hum Genet 1985;37:199-207.
3. Bixel G, Kloep S, Butz S, Petri B, Engelhardt B, Vestweber D. Mouse CD99 participates in T cell recruitment into inflamed skin. Blood 2004;104:3205-13.
4. Park SH, Shin YK, Suh YH, et al. Rapid divergency of rodent CD99 orthologs: implications for the evolution of the pseudoautosomal region. Gene 2005:353:177-88.
5. Banting GS, Pym B, Darling SM, Goodfellow PN. The MIC2 gene product: epitope mapping and structural prediction analysis define an integral membrane protein. Mol Immunol 1989;26:181-8.